Literature DB >> 22759757

In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria.

Sibel Dosler1, A Alev Gerceker.   

Abstract

The In vitro activities of two antimicrobial cationic peptides, melittin and nisin alone and in combination with frequently used antibiotics (daptomycin, vancomycin, linezolid, ampicillin, and erythromycin), were assessed against clinical isolates of methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Enterococcus faecalis. Using the broth microdilution method, minimum inhibitory concentration (MIC) ranges of melittin and nisin against all strains were 2-8 μg/ml and 2-32 μg/ml respectively. In combination studies performed with the microdilution checkerboard method using a fractional inhibitory concentration index of ≤ 0.5 as borderline, synergistic interactions occurred more frequently with nisin-ampicillin combination against MSSA and nisin-daptomycin combination against E. faecalis strains. The results of the time-killing curve analysis demonstrated that the concentration dependent rapid bactericidal activity of nisin, and that synergism or early synergism was detected in most strains when nisin or melittin was used in combination with antibiotics even at concentrations of 0.5 × MIC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759757     DOI: 10.1179/1973947812Y.0000000007

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  21 in total

Review 1.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

2.  Effect of nisin and perilla oil combination against Listeria monocytogenes and Staphylococcus aureus in milk.

Authors:  Xingchen Zhao; Ce Shi; Rizeng Meng; Zonghui Liu; Yanjun Huang; Ziwen Zhao; Na Guo
Journal:  J Food Sci Technol       Date:  2016-06-09       Impact factor: 2.701

Review 3.  Applications and evolution of melittin, the quintessential membrane active peptide.

Authors:  Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley
Journal:  Biochem Pharmacol       Date:  2021-09-17       Impact factor: 6.100

4.  Insect antimicrobial peptides act synergistically to inhibit a trypanosome parasite.

Authors:  Monika Marxer; Vera Vollenweider; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

5.  Helical Structure of Recombinant Melittin.

Authors:  Lisa S Ramirez; Jayanti Pande; Alexander Shekhtman
Journal:  J Phys Chem B       Date:  2019-01-04       Impact factor: 3.466

Review 6.  Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Magdalena Ratajczak; Dorota Kaminska; Eliza Matuszewska; Elżbieta Hołderna-Kedzia; Jarosław Rogacki; Jan Matysiak
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

7.  An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis.

Authors:  Zhongchun Tong; Yuejiao Zhang; Junqi Ling; Jinglei Ma; Lijia Huang; Luodan Zhang
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 8.  Recent advances in developing insect natural products as potential modern day medicines.

Authors:  Norman Ratcliffe; Patricia Azambuja; Cicero Brasileiro Mello
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-06       Impact factor: 2.629

9.  In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms.

Authors:  Des Field; Rory O' Connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Front Microbiol       Date:  2016-04-18       Impact factor: 5.640

10.  In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria.

Authors:  Parvin Askari; Mohammad Hasan Namaei; Kiarash Ghazvini; Mehran Hosseini
Journal:  BMC Pharmacol Toxicol       Date:  2021-07-14       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.